Russell Investments Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.04M Sell
46,935
-91,361
-66% -$2.18M ﹤0.01% 2190
2025
Q4
$3.69M Buy
138,296
+59,313
+75% +$1.42M ﹤0.01% 1511
2025
Q3
$1.69M Buy
78,983
+31,298
+66% +$740K ﹤0.01% 1950
2025
Q2
$1.03M Sell
47,685
-193,638
-80% -$3.6M ﹤0.01% 2054
2025
Q1
$4.01M Buy
241,323
+43,523
+22% +$791K 0.01% 1285
2024
Q4
$3.63M Sell
197,800
-69,139
-26% -$1.12M 0.01% 1330
2024
Q3
$4.11M Sell
266,939
-49,155
-16% -$820K 0.01% 1289
2024
Q2
$5.14M Buy
316,094
+295,405
+1,428% +$4.77M 0.01% 1132
2024
Q1
$383K Buy
20,689
+2,264
+12% +$56.1K ﹤0.01% 2286
2023
Q4
$577K Sell
18,425
-302,412
-94% -$7.22M ﹤0.01% 2165
2023
Q3
$6.69M Sell
320,837
-15,937
-5% -$433K 0.01% 944
2023
Q2
$8.07M Buy
336,774
+11,964
+4% +$266K 0.02% 880
2023
Q1
$6.11M Buy
324,810
+88,043
+37% +$1.68M 0.01% 1017
2022
Q4
$3.77M Buy
236,767
+47,270
+25% +$739K 0.01% 1240
2022
Q3
$3.1M Buy
189,497
+134,468
+244% +$2.18M 0.01% 1316
2022
Q2
$774K Sell
55,029
-75,076
-58% -$1.4M ﹤0.01% 2073
2022
Q1
$3.15M Sell
130,105
-8,845
-6% -$214K 0.01% 1405
2021
Q4
$3.24M Buy
138,950
+11,172
+9% +$225K 0.01% 1523
2021
Q3
$2.12M Buy
127,778
+113,179
+775% +$2.18M ﹤0.01% 1802
2021
Q2
$355K Sell
14,599
-12,825
-47% -$289K ﹤0.01% 2724
2021
Q1
$705K Buy
27,424
+3,062
+13% +$135K ﹤0.01% 2382
2020
Q4
$1.3M Buy
24,362
+13,023
+115% +$646K ﹤0.01% 1986
2020
Q3
$467K Sell
11,339
-42,666
-79% -$1.84M ﹤0.01% 2421
2020
Q2
$2.61M Sell
54,005
-76,938
-59% -$3.69M 0.01% 1482
2020
Q1
$5.53M Buy
130,943
+46,528
+55% +$1.92M 0.01% 895
2019
Q4
$3.61M Buy
84,415
+4,127
+5% +$180K 0.01% 1406
2019
Q3
$2.89M Sell
80,288
-10,550
-12% -$320K 0.01% 1490
2019
Q2
$2.43M Sell
90,838
-3,401
-4% -$86.9K ﹤0.01% 1581
2019
Q1
$2.53M Buy
94,239
+85,677
+1,001% +$2M ﹤0.01% 1597
2018
Q4
$139K Hold
8,562
﹤0.01% 2669
2018
Q3
$178K Buy
8,562
+4,202
+96% +$66.1K ﹤0.01% 2669
2018
Q2
$66K Sell
4,360
-1,957
-31% -$34.9K ﹤0.01% 2781
2018
Q1
$142K Sell
6,317
-141
-2% -$3.9K ﹤0.01% 2705
2017
Q4
$201K Sell
6,458
-6,501
-50% -$208K ﹤0.01% 2668
2017
Q3
$488K Buy
12,959
+1,500
+13% +$48.8K ﹤0.01% 2448
2017
Q2
$319K Sell
11,459
-12,691
-53% -$378K ﹤0.01% 2575
2017
Q1
$831K Buy
24,150
+19,116
+380% +$675K ﹤0.01% 2198
2016
Q4
$145K Buy
+5,034
New +$133K ﹤0.01% 2783

Other funds holding ACAD